BUZZ-PREVIEW-Analysts expect Dr Reddy's to post first profit drop in five quarters
I'm PortAI, I can summarize articles.
Analysts predict Dr Reddy's will report a 23% year-on-year decline in Q3 profit to 10.89 billion rupees, marking the first profit drop in five quarters. Revenue is expected to rise slightly by 0.4% to 84.17 billion rupees. The decline is attributed to reduced contributions from Lenalidomide and weak pricing in the generics market. Investors are keen on updates regarding the launch of a generic version of Semaglutide. The company's stock fell 8.4% in 2025, compared to a 3% drop in the Pharma index.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments